Effects of senescence on the tumour microenvironment and response to therapy
The FEBS Journal · 2024
DOI: 10.1111/febs.16984 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, 2024. Verfasst von Louise E Reynolds und 5 weiteren Autor:innen. Beteiligte Einrichtung: Adhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, Barts Cancer Institute, John Vane Science Centre, Queen Mary University London, UK. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Cellular Senescence, Senescence-Associated Secretory Phenotype. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Tumour Charity, Cancer Research UK, Wellcome Trust.
Abstract (Originalsprache)
Cellular senescence is a state of durable cell arrest that has been identified both in vitro and in vivo . It is associated with profound changes in gene expression and a specific secretory profile that includes pro‐inflammatory cytokines, growth factors and matrix‐remodelling enzymes, referred to as the senescence‐associated secretory phenotype (SASP). In cancer, senescence can have anti‐ or pro‐tumour effects. On one hand, it can inhibit tumour progression in a cell autonomous manner. On the other hand, senescence can also promote tumour initiation, progression, metastatic dissemination and resistance to therapy in a paracrine manner. Therefore, despite efforts to target senescence as a potential strategy to inhibit tumour growth, senescent cancer and microenvironmental cells can eventually lead to uncontrolled proliferation and aggressive tumour phenotypes. This can happen either through overcoming senescence growth arrest or through SASP‐mediated effects in adjacent tumour cells. This review will discuss how senescence affects the tumour microenvironment, including extracellular matrix remodelling, the immune system and the vascular compartment, to promote tumourigenesis, metastasis and resistance to DNA‐damaging therapies. It will also discuss current approaches used in the field to target senescence: senolytics, improving the immune clearance of senescent cells and targeting the SASP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, Barts Cancer Institute, John Vane Science Centre, Queen Mary University London, UK.
- Developmental Biology and Cancer Programme, Birth Defects Research Centre, UCL Great Ormond Street Institute of Child Health, University College London, UK.
ORCID-Profile: Kairbaan M Hodivala-Dilke, Ana-Rita Pedrosa
Förderung
- Brain Tumour Charity
- Cancer Research UK
- Wellcome Trust
- Medical Research Council
- Queen Mary University London
- University College London
- CHILDREN with CANCER UK
- National Institute of Health Research Biomedical Research Centre at the Great Ormond Street Hospital for Children NHS Foundation Trust
Zitieren
APA
Reynolds, L. E., Maallin, S., Haston, S., Martinez-Barbera, J. P., Hodivala-Dilke, K. M., & Pedrosa, A. R. (2024). Effects of senescence on the tumour microenvironment and response to therapy. The FEBS Journal. https://doi.org/10.1111/febs.16984
Vancouver
Reynolds LE, Maallin S, Haston S, Martinez-Barbera JP, Hodivala-Dilke KM, Pedrosa AR. Effects of senescence on the tumour microenvironment and response to therapy. The FEBS Journal. 2024. doi:10.1111/febs.16984
BibTeX
@article{Reynolds2024,
author = {Reynolds, Louise E and Maallin, Seynab and Haston, Scott and Martinez-Barbera, Juan Pedro and Hodivala-Dilke, Kairbaan M and Pedrosa, Ana-Rita},
title = {Effects of senescence on the tumour microenvironment and response to therapy},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.16984}
}
EUVIMED